ABL Bio Inc.
Yongsun Kwon currently serves as the Director of Business Operations at ABL Bio Inc. since September 2022. Prior to this role, Yongsun Kwon was the Senior Talent Management & Staffing Manager at Baxter Healthcare from May 2009 to September 2017. Additional experience includes a position as a Human Resources Consultant at IBM Korea for a brief period in 2007, and a tenure as both a Training Specialist and Benefit Specialist at Hewlett-Packard from March 2001 to April 2007. Yongsun Kwon holds a Master of Arts (M.A.) in Educational/Instructional Technology from Ewah Women's University.
This person is not in any teams
This person is not in any offices
ABL Bio Inc.
ABL Bio Inc. (Kosdaq: 298380) is a South Korean biotechnology company dedicated to the development of bispecific antibody therapeutics to improve and save people's lives. With our BsAb platforms ‘Grabody-T,’ ‘Grabody-I’ and ‘Grabody-B,’ we have built a robust pipeline of multiple clinical and pre-clinical stage drug candidates. In the oncology area, we have developed Grabody-T, a modular 4-1BB engaging platform that has demonstrated excellent efficacy and safety. We also created a next-generation antibody drug conjugate program to treat various cancers. In the neurodegenerative disorder space, we have developed Grabody-B platform, which is designed to maximize blood-brain barrier (BBB) penetration. Grabody-B is applicable to various CNS targets across a plethora of neurological disorders, potentially providing a breakthrough to address the high unmet medical needs in neurodegeneration. We continue to actively expand and advance our pipeline through global strategic partnerships. For more information, please visit http://ablbio.com